Cindy Jacobs
2009
In 2009, Cindy Jacobs earned a total compensation of $656.3K as Executive Vice President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 69% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $108,000 |
|---|---|
| Option Awards | $188,314 |
| Salary | $360,000 |
| Total | $656,314 |
Jacobs received $360K in salary, accounting for 55% of the total pay in 2009.
Jacobs also received $108K in non-equity incentive plan and $188.3K in option awards.
Rankings
In 2009, Cindy Jacobs' compensation ranked 5,905th out of 9,885 executives tracked by ExecPay. In other words, Jacobs earned more than 40.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,905 out of 9,885 | 40th |
Division Manufacturing | 2,128 out of 3,690 | 42nd |
Major group Chemicals And Allied Products | 453 out of 866 | 48th |
Industry group Drugs | 298 out of 638 | 53rd |
Industry In Vitro and In Vivo Diagnostic Substances | 21 out of 44 | 52nd |
Source: SEC filing on April 21, 2011.
Jacobs' colleagues
We found two more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2009.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019